Robert T Chang, MD
Ophthalmology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A108857 · Current
Licensed to practise in California · since 2009 · expires 2028-12-31 · University of Missouri-Kansas City School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Florida ME99224Medical Doctor · since 2007 · expires 2027-01-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
3 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- Ophthalmology
Education
- University of Missouri-Kansas City · md2002–2002Medical school
Residency and fellowship
- Bascom Palmer Eye Institute, OtherMIAMI, FL · 2007–2009
- Washington University in St Louis, OphthalmologyST LOUIS, MO · 2004–2007
- Evanston Northwestern Healthcare, Transitional YearEVANSTON, IL · 2003–2004
What else the board holds
Hospitals they may admit to
Where the clinician told their state board they may admit and treat patients.
- Out of State · CA
Also licensed in
States the clinician told their board they are also licensed in. Only the states we check are verified.
California · Missouri
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$273,146
Medicare paid this office $273,146 for 752 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of cataract with insertion of prosthetic lens | 74 | $51,331 | $503 |
| Return visit (30+ min) | 342 | $40,238 | $78 |
| Short return visit (20+ min) | 267 | $21,063 | $54 |
| Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | 19 | $17,521 | $649 |
| Complex removal of cataract with insertion of prosthetic lens | 20 | $16,165 | $703 |
See all 22 services
| Removal of cataract with insertion of prosthetic lens | 74 | $51,331 | $503 |
| Return visit (30+ min) | 342 | $40,238 | $78 |
| Short return visit (20+ min) | 267 | $21,063 | $54 |
| Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | 19 | $17,521 | $649 |
| Complex removal of cataract with insertion of prosthetic lens | 20 | $16,165 | $703 |
| Creation of shunt to improve eye fluid flow using tissue graft | 13 | $16,119 | $1,075 |
| Long return visit (40+ min) | 108 | $12,919 | $116 |
| Removal of recurring cataract in lens capsule using a laser | 41 | $12,655 | $301 |
| Exam of visual field with extended testing | 383 | $10,580 | $23 |
| Established patient complete exam of visual system | 144 | $9,092 | $62 |
| Imaging of optic nerve | 457 | $8,914 | $18 |
| Laser repair to improve eye fluid flow | 31 | $7,415 | $190 |
| New patient visit (45+ min) | 44 | $4,569 | $104 |
| Measurement of corneal curvature and depth of eye | 96 | $2,634 | $27 |
| Ct scan of cornea | 120 | $2,616 | $17 |
| Established patient problem focused exam of visual system | 49 | $2,136 | $40 |
| Exam of the internal drainage system of eye | 120 | $2,076 | $17 |
| New patient complete exam of visual system | 21 | $1,462 | $70 |
| Imaging of retina | 68 | $1,413 | $20 |
| Ultrasound scan of cornea to determine thickness | 96 | $630 | $6 |
| Photography of the retina | 31 | $459 | $15 |
| Imaging of front third of eye using a special microscope | 14 | $317 | $17 |
Procedures Medicare counted
| Cataract surgery | 219 | More than 85% of doctors who do this |
Who their Medicare patients are
752 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 18% · Women 57% · Also on Medicaid 23% · Health risk score 1.16. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 66% · Diabetes 31% · Coronary heart disease 20% · Chronic kidney disease 20% · Atrial fibrillation 15% · Cancer 14% · Heart failure 13% · Depression 11% · COPD 9% · Dementia 5% · Stroke 5%.
The office billed $1,794,293, Medicare allowed $364,384 and paid $273,146; for 3,165 services of 50 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 752 | 3,165 | 77 | 1.16 | $1,794,293 | $273,146 |
| 2023 | 666 | 2,430 | 77 | 1.11 | $1,698,100 | $256,757 |
| 2022 | 619 | 2,313 | 76 | 1.13 | $1,522,920 | $237,105 |
| 2021 | 659 | 2,807 | 76 | 1.15 | $1,766,894 | $287,373 |
| 2020 | 560 | 2,182 | 76 | 1.24 | $1,302,944 | $198,474 |
| 2019 | 614 | 2,360 | 76 | 1.22 | $1,623,426 | $233,695 |
| 2018 | 658 | 2,193 | 76 | 1.20 | $1,375,791 | $195,142 |
| 2017 | 746 | 2,523 | 75 | 1.27 | $1,542,076 | $228,399 |
| 2016 | 762 | 2,649 | 76 | 1.22 | $1,700,424 | $254,454 |
| 2015 | 733 | 2,333 | 75 | 1.24 | $1,359,703 | $215,168 |
| 2014 | 728 | 2,365 | 75 | 1.15 | $1,523,882 | $233,112 |
| 2013 | 622 | 1,946 | 75 | 1.12 | $1,101,466 | $177,717 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Removal of cataract with insertion of prosthetic lens | 57 | $36,276 | $511 |
| Return visit (30+ min) | 283 | $30,289 | $80 |
| Complex removal of cataract with insertion of prosthetic lens | 30 | $29,065 | $727 |
| Creation of shunt to improve eye fluid flow using tissue graft | 19 | $23,191 | $1,104 |
| Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | 26 | $22,804 | $671 |
| Short return visit (20+ min) | 261 | $19,677 | $54 |
| Removal of recurring cataract in lens capsule using a laser | 43 | $14,033 | $312 |
| Long return visit (40+ min) | 86 | $11,278 | $119 |
| Exam of visual field with extended testing | 295 | $8,172 | $24 |
| Imaging of optic nerve | 320 | $6,180 | $19 |
| Established patient complete exam of visual system | 79 | $5,521 | $69 |
| New patient visit (45+ min) | 50 | $5,520 | $110 |
| Laser repair to improve eye fluid flow | 16 | $3,952 | $188 |
| Measurement of corneal curvature and depth of eye | 100 | $2,880 | $28 |
| Ct scan of cornea | 110 | $2,139 | $18 |
| New patient complete exam of visual system | 22 | $1,744 | $79 |
| Imaging of retina | 66 | $1,672 | $22 |
| Exam of the internal drainage system of eye | 67 | $1,216 | $18 |
| Established patient problem focused exam of visual system | 23 | $1,026 | $45 |
| Ultrasound scan of cornea to determine thickness | 54 | $383 | $7 |
| Photography of the retina | 15 | $281 | $19 |
| Imaging of front third of eye using a special microscope | 12 | $246 | $20 |
2022: 21 services
| Removal of cataract with insertion of prosthetic lens | 65 | $44,876 | $504 |
| Return visit (30+ min) | 283 | $31,095 | $76 |
| Complex removal of cataract with insertion of prosthetic lens | 29 | $21,585 | $696 |
| Short return visit (20+ min) | 227 | $16,926 | $53 |
| Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | 17 | $15,601 | $650 |
| Removal of recurring cataract in lens capsule using a laser | 38 | $11,510 | $288 |
| Long return visit (40+ min) | 95 | $11,360 | $114 |
| Exam of visual field with extended testing | 310 | $7,897 | $22 |
| New patient visit (45+ min) | 57 | $6,002 | $105 |
| Established patient complete exam of visual system | 84 | $4,997 | $59 |
| Imaging of optic nerve | 264 | $4,984 | $18 |
| Laser repair to improve eye fluid flow | 20 | $4,224 | $201 |
| Established patient problem focused exam of visual system | 65 | $2,521 | $39 |
| Measurement of corneal curvature and depth of eye | 74 | $1,951 | $26 |
| Ct scan of cornea | 73 | $1,554 | $16 |
| Imaging of retina | 52 | $1,350 | $23 |
| New patient complete exam of visual system | 14 | $997 | $71 |
| Exam of the internal drainage system of eye | 42 | $736 | $18 |
| Imaging of front third of eye using a special microscope | 14 | $309 | $18 |
| Ultrasound scan of cornea to determine thickness | 30 | $222 | $7 |
| Photography of the retina | 13 | $200 | $13 |
2021: 22 services
| Removal of cataract with insertion of prosthetic lens | 88 | $59,960 | $517 |
| Return visit (30+ min) | 319 | $38,813 | $75 |
| Creation of shunt to improve eye fluid flow using tissue graft | 22 | $29,919 | $1,108 |
| Complex removal of cataract with insertion of prosthetic lens | 34 | $26,346 | $712 |
| Internal insertion of eye fluid drainage device | 38 | $15,021 | $327 |
| Long return visit (40+ min) | 100 | $12,181 | $117 |
| Established patient complete exam of visual system | 133 | $9,959 | $71 |
| Exam of visual field with extended testing | 325 | $8,803 | $22 |
| Established patient problem focused exam of visual system | 145 | $8,232 | $48 |
| New patient visit (45+ min) | 69 | $7,726 | $112 |
| Short return visit (20+ min) | 142 | $7,555 | $46 |
| Removal of recurring cataract in lens capsule using a laser | 23 | $6,863 | $275 |
| Imaging of optic nerve | 303 | $5,613 | $18 |
| Laser repair to improve eye fluid flow | 19 | $3,727 | $162 |
| Measurement of corneal curvature and depth of eye | 110 | $3,140 | $28 |
| Ct scan of cornea | 131 | $2,909 | $17 |
| New patient complete exam of visual system | 30 | $2,239 | $75 |
| Exam of the internal drainage system of eye | 90 | $1,592 | $18 |
| Imaging of retina | 44 | $1,222 | $24 |
| Ultrasound scan of cornea to determine thickness | 76 | $458 | $6 |
| Imaging of front third of eye using a special microscope | 13 | $295 | $20 |
| Photography of the retina | 12 | $223 | $19 |
2020: 18 services
| Removal of cataract with insertion of prosthetic lens | 66 | $50,583 | $527 |
| Creation of shunt to improve eye fluid flow using tissue graft | 22 | $25,484 | $1,019 |
| Established patient complete exam of visual system | 285 | $24,081 | $62 |
| Established patient problem focused exam of visual system | 269 | $19,805 | $43 |
| Complex removal of cataract with insertion of prosthetic lens | 11 | $8,160 | $742 |
| Removal of recurring cataract in lens capsule using a laser | 22 | $7,850 | $314 |
| Exam of visual field with extended testing | 281 | $7,571 | $24 |
| Imaging of optic nerve | 263 | $5,057 | $18 |
| Long return visit (40+ min) | 43 | $4,172 | $95 |
| New patient complete exam of visual system | 51 | $3,978 | $78 |
| Internal insertion of eye fluid drainage device | 12 | $3,742 | $249 |
| New patient visit (45+ min) | 33 | $3,126 | $95 |
| Measurement of corneal curvature and depth of eye | 69 | $2,018 | $29 |
| Ct scan of cornea | 91 | $1,791 | $16 |
| Exam of the internal drainage system of eye | 70 | $1,324 | $18 |
| Short return visit (20+ min) | 11 | $666 | $44 |
| Imaging of retina | 23 | $494 | $19 |
| Ultrasound scan of cornea to determine thickness | 52 | $357 | $7 |
2019: 20 services
| Removal of cataract with insertion of prosthetic lens | 81 | $64,806 | $584 |
| Established patient complete exam of visual system | 368 | $29,719 | $62 |
| Creation of shunt to improve eye fluid flow using tissue graft | 21 | $23,079 | $1,049 |
| Established patient problem focused exam of visual system | 291 | $20,557 | $45 |
| Dilation of fluid outflow drainage within eye | 14 | $14,725 | $920 |
| Complex removal of cataract with insertion of prosthetic lens | 15 | $12,207 | $678 |
| Removal of recurring cataract in lens capsule using a laser | 24 | $7,890 | $292 |
| Exam of visual field with extended testing | 281 | $7,740 | $23 |
| Internal insertion of eye fluid drainage device | 25 | $6,815 | $200 |
| Imaging of optic nerve | 284 | $5,575 | $18 |
| Incision to improve eye fluid flow | 11 | $4,574 | $381 |
| Long return visit (40+ min) | 43 | $3,888 | $88 |
| New patient complete exam of visual system | 32 | $2,625 | $82 |
| New patient visit (45+ min) | 24 | $2,392 | $100 |
| Measurement of corneal curvature and depth of eye | 83 | $2,380 | $29 |
| Ct scan of cornea | 107 | $2,232 | $16 |
| Exam of the internal drainage system of eye | 65 | $1,215 | $19 |
| Imaging of retina | 20 | $516 | $22 |
| Ultrasound scan of cornea to determine thickness | 43 | $303 | $7 |
| Photography of the retina | 14 | $290 | $21 |
2018: 19 services
| Removal of cataract with insertion of prosthetic lens | 77 | $61,239 | $595 |
| Established patient complete exam of visual system | 328 | $24,558 | $62 |
| Established patient problem focused exam of visual system | 369 | $22,340 | $41 |
| Complex removal of cataract with insertion of prosthetic lens | 20 | $16,396 | $713 |
| Creation of shunt to improve eye fluid flow using tissue graft | 12 | $12,942 | $1,079 |
| Exam of visual field with extended testing | 254 | $6,679 | $24 |
| Removal of recurring cataract in lens capsule using a laser | 22 | $6,674 | $290 |
| Imaging of optic nerve | 267 | $4,963 | $18 |
| Internal insertion of eye fluid drainage device | 16 | $3,936 | $187 |
| Long return visit (40+ min) | 35 | $3,293 | $94 |
| New patient complete exam of visual system | 44 | $3,104 | $71 |
| Laser repair to improve eye fluid flow | 12 | $2,836 | $189 |
| Ct scan of cornea | 96 | $1,827 | $16 |
| New patient visit (45+ min) | 22 | $1,742 | $79 |
| Measurement of corneal curvature and depth of eye | 63 | $1,699 | $27 |
| Exam of the internal drainage system of eye | 64 | $1,011 | $16 |
| Imaging of retina | 25 | $565 | $22 |
| Photography of the retina | 19 | $366 | $19 |
| Ultrasound scan of cornea to determine thickness | 46 | $283 | $6 |
2017: 23 services
| Removal of cataract with insertion of prosthetic lens | 91 | $70,344 | $577 |
| Established patient problem focused exam of visual system | 436 | $28,439 | $43 |
| Established patient complete exam of visual system | 286 | $21,751 | $65 |
| Creation of shunt to improve eye fluid flow using tissue graft | 14 | $16,877 | $1,055 |
| Complex removal of cataract with insertion of prosthetic lens | 17 | $12,426 | $731 |
| Internal insertion of eye fluid drainage device | 12 | $8,412 | $647 |
| Destruction of tissue encircling lens using an endoscope | 13 | $7,543 | $539 |
| Exam of visual field with extended testing | 256 | $7,116 | $23 |
| Removal of recurring cataract in lens capsule using a laser | 23 | $6,661 | $278 |
| New patient complete exam of visual system | 75 | $5,946 | $79 |
| Destruction of lens tissue using laser | 15 | $5,369 | $358 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 16 | $4,923 | $214 |
| Laser repair to improve eye fluid flow | 24 | $4,472 | $172 |
| Imaging of optic nerve | 228 | $4,402 | $18 |
| Long return visit (40+ min) | 49 | $4,386 | $90 |
| New patient visit (45+ min) | 33 | $3,445 | $104 |
| Measurement of corneal curvature and depth of eye | 106 | $3,372 | $27 |
| Ct scan of cornea | 115 | $2,082 | $17 |
| Exam of the internal drainage system of eye | 108 | $1,971 | $18 |
| Ultrasound scan of cornea to determine thickness | 100 | $793 | $8 |
| Imaging of retina | 32 | $772 | $23 |
| Short return visit (20+ min) | 12 | $456 | $35 |
| Photography of the retina | 12 | $224 | $19 |
2016: 21 services
| Removal of cataract with insertion of prosthetic lens | 97 | $71,496 | $567 |
| Established patient problem focused exam of visual system | 451 | $30,071 | $42 |
| Internal insertion of eye fluid drainage device | 20 | $25,192 | $933 |
| Established patient complete exam of visual system | 278 | $19,537 | $63 |
| Creation of shunt to improve eye fluid flow using tissue graft | 16 | $18,366 | $1,080 |
| Complex removal of cataract with insertion of prosthetic lens | 11 | $10,126 | $723 |
| Exam of visual field with extended testing | 309 | $9,427 | $23 |
| Removal of recurring cataract in lens capsule using a laser | 23 | $7,393 | $284 |
| Imaging of optic nerve | 243 | $5,744 | $23 |
| New patient complete exam of visual system | 71 | $5,334 | $75 |
| Laser repair to improve eye fluid flow | 18 | $4,500 | $237 |
| Long return visit (40+ min) | 46 | $3,914 | $85 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 11 | $3,571 | $210 |
| New patient visit (45+ min) | 35 | $2,942 | $84 |
| Exam of the internal drainage system of eye | 136 | $2,422 | $18 |
| Measurement of corneal curvature and depth of eye | 73 | $2,356 | $28 |
| Ct scan of cornea | 60 | $1,200 | $18 |
| Ultrasound scan of cornea to determine thickness | 118 | $1,026 | $9 |
| Imaging of retina | 35 | $921 | $26 |
| Short return visit (20+ min) | 12 | $547 | $46 |
| Photography of the retina | 21 | $430 | $20 |
2015: 18 services
| Removal of cataract with insertion of prosthetic lens | 77 | $61,130 | $588 |
| Established patient problem focused exam of visual system | 394 | $28,575 | $44 |
| Established patient complete exam of visual system | 296 | $21,766 | $64 |
| Internal insertion of eye fluid drainage device | 13 | $12,970 | $926 |
| Creation of shunt to improve eye fluid flow using tissue graft | 12 | $12,477 | $1,040 |
| Complex removal of cataract with insertion of prosthetic lens | 12 | $11,237 | $749 |
| Laser repair to improve eye fluid flow | 24 | $8,694 | $272 |
| New patient complete exam of visual system | 104 | $7,995 | $77 |
| Exam of visual field with extended testing | 236 | $6,359 | $24 |
| Removal of recurring cataract in lens capsule using a laser | 19 | $6,214 | $296 |
| Imaging of optic nerve | 237 | $5,900 | $24 |
| Exam of the internal drainage system of eye | 136 | $2,543 | $19 |
| New patient visit (45+ min) | 24 | $2,492 | $104 |
| Measurement of corneal curvature and depth of eye | 55 | $1,511 | $27 |
| Ultrasound scan of cornea to determine thickness | 100 | $886 | $9 |
| Imaging of retina | 33 | $833 | $24 |
| Ct scan of cornea | 30 | $593 | $18 |
| Photography of the retina | 25 | $512 | $20 |
2014: 19 services
| Removal of cataract with insertion of prosthetic lens | 80 | $65,902 | $599 |
| Established patient complete exam of visual system | 383 | $31,996 | $65 |
| Established patient problem focused exam of visual system | 315 | $22,506 | $44 |
| Creation of shunt to improve eye fluid flow using tissue graft | 12 | $15,523 | $1,109 |
| Complex removal of cataract with insertion of prosthetic lens | 18 | $14,452 | $723 |
| New patient complete exam of visual system | 111 | $8,436 | $76 |
| Repair of defect of sclera with graft | 13 | $8,368 | $523 |
| Removal of recurring cataract in lens capsule using a laser | 21 | $7,297 | $304 |
| Exam of visual field with extended testing | 258 | $6,520 | $22 |
| Imaging of optic nerve | 173 | $4,598 | $25 |
| Laser repair to improve eye fluid flow | 15 | $4,549 | $284 |
| Destruction of tissue encircling lens using an endoscope | 11 | $4,414 | $401 |
| Exam of the internal drainage system of eye | 137 | $2,578 | $19 |
| New patient visit (45+ min) | 26 | $2,043 | $79 |
| Measurement of corneal curvature and depth of eye | 73 | $1,963 | $27 |
| Imaging of retina | 58 | $1,566 | $25 |
| Ultrasound scan of cornea to determine thickness | 108 | $952 | $9 |
| Ct scan of cornea | 25 | $505 | $19 |
| Photography of the retina | 26 | $498 | $18 |
2013: 14 services
| Removal of cataract with insertion of prosthetic lens | 69 | $55,558 | $604 |
| Established patient complete exam of visual system | 345 | $26,522 | $65 |
| Established patient problem focused exam of visual system | 266 | $21,867 | $44 |
| Creation of shunt to improve eye fluid flow using tissue graft | 12 | $12,255 | $1,021 |
| Exam of visual field with extended testing | 226 | $6,680 | $24 |
| New patient complete exam of visual system | 82 | $6,264 | $76 |
| Removal of recurring cataract in lens capsule using a laser | 17 | $4,858 | $286 |
| Imaging of optic nerve | 146 | $3,713 | $24 |
| Measurement of corneal curvature and depth of eye | 58 | $1,573 | $27 |
| Exam of the internal drainage system of eye | 87 | $1,566 | $18 |
| New patient visit (45+ min) | 12 | $1,020 | $85 |
| Imaging of retina | 33 | $893 | $26 |
| Photography of the retina | 34 | $708 | $21 |
| Ultrasound scan of cornea to determine thickness | 72 | $594 | $8 |
Medicaid work
$5,793 in 2024
Medicaid paid $5,793 for 347 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 89 | $2,843 |
| Short return visit (20+ min) | 37 | $1,121 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 111 | $1,061 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 110 | $768 |
| 2024 | 347 | 4 | 23 | $5,793 |
| 2023 | 331 | 5 | 23 | $5,148 |
| 2022 | 196 | 3 | 20 | $3,211 |
| 2021 | 342 | 6 | 38 | $7,095 |
| 2020 | 334 | 4 | 24 | $6,222 |
| 2019 | 495 | 4 | 25 | $8,356 |
| 2018 | 433 | 5 | 30 | $5,874 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 83 | $1,765 |
| Short return visit (20+ min) | 92 | $1,312 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 97 | $1,187 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 47 | $616 |
| Service | 12 | $268 |
2022
| Return visit (30+ min) | 83 | $1,597 |
| Short return visit (20+ min) | 60 | $940 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 53 | $675 |
2021
| Return visit (30+ min) | 154 | $4,130 |
| Short return visit (20+ min) | 37 | $953 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 63 | $908 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 59 | $801 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 16 | $303 |
| Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr) | 13 | $0 |
2020
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 159 | $3,747 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 98 | $1,553 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 51 | $587 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 26 | $336 |
2019
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 193 | $4,308 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 133 | $1,584 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 101 | $1,324 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 68 | $1,140 |
2018
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 160 | $2,610 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 117 | $1,561 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 87 | $1,057 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 56 | $588 |
| Injection, adrenalin, epinephrine, 0.1 mg | 13 | $59 |
Drugs they prescribed that Part D paid
$300,983
Pharmacies billed $300,983 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
805 generic and 979 brand-name prescriptions · $300,983 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 65 | $46,574 | $717 |
| Rocklatan | 76 | $43,527 | $573 |
| Xiidra | 43 | $31,416 | $731 |
| Cyclosporine | 79 | $20,563 | $260 |
| Tyrvaya | 21 | $18,984 | $904 |
See all 29 drugs
| Restasis | 65 | $46,574 | $717 |
| Rocklatan | 76 | $43,527 | $573 |
| Xiidra | 43 | $31,416 | $731 |
| Cyclosporine | 79 | $20,563 | $260 |
| Tyrvaya | 21 | $18,984 | $904 |
| Lumigan | 39 | $18,641 | $478 |
| Rhopressa | 40 | $15,826 | $396 |
| Azopt | 17 | $12,882 | $758 |
| Combigan | 20 | $9,757 | $488 |
| Simbrinza | 43 | $9,317 | $217 |
| Methazolamide | 49 | $8,310 | $170 |
| Prednisolone Acetate | 202 | $7,947 | $39 |
| Brimonidine | 80 | $7,066 | $88 |
| Alphagan P | 12 | $6,465 | $539 |
| Tafluprost | 51 | $6,300 | $124 |
| Brimonidine Tartrate-Timolol | 44 | $5,624 | $128 |
| Dorzolamide-Timolol | 36 | $3,942 | $110 |
| Brinzolamide | 16 | $3,855 | $241 |
| Latanoprost | 369 | $2,916 | $8 |
| Dorzolamide-Timolol | 107 | $1,785 | $17 |
| Timolol Maleate | 131 | $1,588 | $12 |
| Acetazolamide | 29 | $1,248 | $43 |
| Ketorolac Tromethamine | 48 | $717 | $15 |
| Atropine Sulfate | 16 | $688 | $43 |
| Azelastine | 24 | $628 | $26 |
| Acetazolamide Er | 12 | $587 | $49 |
| Dorzolamide | 26 | $581 | $22 |
| Erythromycin | 26 | $424 | $16 |
| Moxifloxacin | 15 | $289 | $19 |
Year by year
| 2024 | 1,784 | 445 | None | 55% | $300,983 |
| 2023 | 1,656 | 393 | None | 59% | $330,465 |
| 2022 | 1,931 | 413 | None | 58% | $384,462 |
| 2021 | 2,642 | 490 | None | 59% | $496,663 |
| 2020 | 2,177 | 408 | 0% (0) | 56% | $408,123 |
| 2019 | 1,390 | 384 | None | 60% | $267,523 |
| 2018 | 1,863 | 381 | None | 56% | $330,627 |
| 2017 | 2,490 | 503 | 0% (0) | 58% | $388,440 |
| 2016 | 2,405 | 451 | None | 59% | $333,798 |
| 2015 | 2,061 | 366 | 0% (0) | 60% | $250,085 |
| 2014 | 2,087 | 377 | None | 61% | $211,528 |
| 2013 | 1,874 | 305 | None | 58% | $165,536 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Restasis | 102 | $83,230 | $816 |
| Rocklatan | 47 | $28,906 | $615 |
| Lumigan | 63 | $27,664 | $439 |
| Rhopressa | 54 | $27,626 | $512 |
| Combigan | 40 | $23,205 | $580 |
| Cyclosporine | 46 | $14,338 | $312 |
| Alphagan P | 20 | $13,241 | $662 |
| Brimonidine Tartrate-Timolol | 45 | $10,709 | $238 |
| Tafluprost | 52 | $7,384 | $142 |
| Zioptan | 23 | $6,780 | $295 |
| Latanoprost | 398 | $6,519 | $16 |
| Prednisolone Acetate | 143 | $6,426 | $45 |
| Cosopt Pf | 22 | $6,335 | $288 |
| Methazolamide | 43 | $6,191 | $144 |
| Travoprost | 20 | $5,814 | $291 |
| Dorzolamide-Timolol | 30 | $4,596 | $153 |
| Azopt | 11 | $4,410 | $401 |
| Simbrinza | 14 | $4,066 | $290 |
| Timolol Maleate | 124 | $2,777 | $22 |
| Dorzolamide-Timolol | 73 | $2,254 | $31 |
| Acetazolamide | 21 | $2,128 | $101 |
| Brimonidine | 55 | $1,818 | $33 |
| Dorzolamide | 36 | $1,262 | $35 |
| Ketorolac Tromethamine | 39 | $1,000 | $26 |
| Azelastine | 32 | $792 | $25 |
| Moxifloxacin | 11 | $284 | $26 |
| Erythromycin | 15 | $224 | $15 |
2022: 25 drugs
| Restasis | 149 | $110,658 | $743 |
| Combigan | 58 | $30,727 | $530 |
| Rocklatan | 71 | $29,882 | $421 |
| Lumigan | 59 | $25,936 | $440 |
| Zioptan | 66 | $21,395 | $324 |
| Rhopressa | 52 | $19,587 | $377 |
| Simbrinza | 50 | $16,769 | $335 |
| Brimonidine Tartrate-Timolol | 46 | $15,291 | $332 |
| Alphagan P | 31 | $13,366 | $431 |
| Azopt | 21 | $10,621 | $506 |
| Xiidra | 13 | $8,743 | $673 |
| Methazolamide | 40 | $8,593 | $215 |
| Latanoprost | 516 | $8,430 | $16 |
| Travoprost | 27 | $6,720 | $249 |
| Dorzolamide-Timolol | 30 | $6,422 | $214 |
| Cosopt Pf | 16 | $6,235 | $390 |
| Prednisolone Acetate | 122 | $5,926 | $49 |
| Brinzolamide | 18 | $5,880 | $327 |
| Dorzolamide-Timolol | 124 | $5,527 | $45 |
| Brimonidine | 91 | $3,579 | $39 |
| Timolol Maleate | 155 | $3,238 | $21 |
| Acetazolamide | 20 | $1,667 | $83 |
| Azelastine | 30 | $1,137 | $38 |
| Dorzolamide | 28 | $914 | $33 |
| Ketorolac Tromethamine | 25 | $632 | $25 |
2021: 29 drugs
| Restasis | 154 | $119,750 | $778 |
| Combigan | 135 | $58,709 | $435 |
| Rocklatan | 81 | $41,201 | $509 |
| Lumigan | 90 | $37,732 | $419 |
| Rhopressa | 83 | $31,688 | $382 |
| Alphagan P | 64 | $28,925 | $452 |
| Simbrinza | 87 | $22,208 | $255 |
| Azopt | 40 | $21,444 | $536 |
| Prednisolone Acetate | 211 | $11,934 | $57 |
| Dorzolamide-Timolol | 49 | $11,527 | $235 |
| Zioptan | 35 | $11,149 | $319 |
| Latanoprost | 600 | $10,239 | $17 |
| Travoprost | 37 | $9,662 | $261 |
| Methazolamide | 50 | $9,391 | $188 |
| Brinzolamide | 25 | $7,859 | $314 |
| Travatan Z | 18 | $7,187 | $399 |
| Brimonidine | 144 | $6,975 | $48 |
| Dorzolamide-Timolol | 144 | $6,454 | $45 |
| Cosopt Pf | 29 | $6,135 | $212 |
| Timolol Maleate | 249 | $4,956 | $20 |
| Acetazolamide | 35 | $4,434 | $127 |
| Vyzulta | 11 | $4,233 | $385 |
| Durezol | 17 | $3,725 | $219 |
| Dorzolamide | 45 | $1,850 | $41 |
| Ketorolac Tromethamine | 51 | $1,277 | $25 |
| Azelastine | 27 | $1,256 | $47 |
| Atropine Sulfate | 15 | $1,049 | $70 |
| Moxifloxacin | 15 | $591 | $39 |
| Erythromycin | 23 | $305 | $13 |
2020: 27 drugs
| Restasis | 126 | $90,409 | $718 |
| Azopt | 60 | $36,047 | $601 |
| Rhopressa | 102 | $32,824 | $322 |
| Combigan | 58 | $32,440 | $559 |
| Lumigan | 86 | $31,389 | $365 |
| Rocklatan | 63 | $27,864 | $442 |
| Alphagan P | 48 | $22,446 | $468 |
| Zioptan | 68 | $21,077 | $310 |
| Simbrinza | 46 | $13,629 | $296 |
| Timoptic Ocudose | 21 | $10,777 | $513 |
| Latanoprost | 532 | $10,140 | $19 |
| Prednisolone Acetate | 137 | $7,613 | $56 |
| Dorzolamide-Timolol | 40 | $7,048 | $176 |
| Timolol Maleate | 244 | $6,897 | $28 |
| Dorzolamide-Timolol | 131 | $5,923 | $45 |
| Acetazolamide | 35 | $5,276 | $151 |
| Cosopt Pf | 24 | $4,679 | $195 |
| Brimonidine | 86 | $4,546 | $53 |
| Methazolamide | 19 | $4,366 | $230 |
| Travatan Z | 11 | $4,270 | $388 |
| Travoprost | 14 | $3,242 | $232 |
| Dorzolamide | 26 | $1,422 | $55 |
| Azelastine | 25 | $959 | $38 |
| Olopatadine | 14 | $733 | $52 |
| Ketorolac Tromethamine | 27 | $682 | $25 |
| Oxybutynin Chloride Er | 11 | $352 | $32 |
| Erythromycin | 20 | $202 | $10 |
2019: 22 drugs
| Restasis | 79 | $53,888 | $682 |
| Lumigan | 81 | $31,813 | $393 |
| Combigan | 49 | $19,265 | $393 |
| Azopt | 36 | $16,302 | $453 |
| Alphagan P | 43 | $14,004 | $326 |
| Travatan Z | 26 | $13,581 | $522 |
| Rhopressa | 40 | $12,185 | $305 |
| Zioptan | 36 | $10,885 | $302 |
| Brimonidine | 64 | $9,746 | $152 |
| Cosopt Pf | 47 | $9,391 | $200 |
| Methazolamide | 33 | $9,066 | $275 |
| Prednisolone Acetate | 143 | $7,848 | $55 |
| Simbrinza | 25 | $5,403 | $216 |
| Latanoprost | 256 | $5,129 | $20 |
| Acetazolamide | 20 | $4,276 | $214 |
| Dorzolamide-Timolol | 92 | $4,003 | $44 |
| Dorzolamide-Timolol | 17 | $3,555 | $209 |
| Durezol | 16 | $3,019 | $189 |
| Timolol Maleate | 120 | $2,487 | $21 |
| Dorzolamide | 28 | $912 | $33 |
| Ketorolac Tromethamine | 19 | $674 | $35 |
| Erythromycin | 11 | $138 | $13 |
2018: 24 drugs
| Restasis | 149 | $88,326 | $593 |
| Lumigan | 87 | $33,616 | $386 |
| Alphagan P | 87 | $31,774 | $365 |
| Azopt | 70 | $31,494 | $450 |
| Combigan | 79 | $26,828 | $340 |
| Travatan Z | 63 | $24,230 | $385 |
| Xiidra | 22 | $11,994 | $545 |
| Zioptan | 42 | $11,208 | $267 |
| Brimonidine | 93 | $10,899 | $117 |
| Latanoprost | 497 | $7,537 | $15 |
| Methazolamide | 28 | $5,763 | $206 |
| Timoptic Ocudose | 14 | $5,623 | $402 |
| Cosopt Pf | 27 | $5,493 | $203 |
| Prednisolone Acetate | 98 | $5,298 | $54 |
| Acetazolamide | 35 | $4,575 | $131 |
| Simbrinza | 12 | $3,721 | $310 |
| Timolol Maleate | 177 | $3,475 | $20 |
| Durezol | 17 | $2,913 | $171 |
| Olopatadine | 25 | $1,944 | $78 |
| Dorzolamide-Timolol | 90 | $1,911 | $21 |
| Dorzolamide | 48 | $1,611 | $34 |
| Azelastine | 23 | $641 | $28 |
| Ketorolac Tromethamine | 16 | $180 | $11 |
| Erythromycin | 11 | $119 | $11 |
2017: 26 drugs
| Lumigan | 191 | $60,028 | $314 |
| Restasis | 117 | $56,463 | $483 |
| Combigan | 147 | $41,594 | $283 |
| Azopt | 96 | $37,076 | $386 |
| Travatan Z | 106 | $27,996 | $264 |
| Brimonidine | 124 | $25,069 | $202 |
| Alphagan P | 68 | $23,242 | $342 |
| Xiidra | 30 | $14,905 | $497 |
| Zioptan | 54 | $10,963 | $203 |
| Prednisolone Acetate | 180 | $10,660 | $59 |
| Latanoprost | 573 | $8,799 | $15 |
| Timoptic Ocudose | 22 | $8,323 | $378 |
| Acetazolamide | 39 | $7,112 | $182 |
| Methazolamide | 44 | $6,963 | $158 |
| Cosopt Pf | 29 | $5,771 | $199 |
| Durezol | 33 | $5,220 | $158 |
| Timolol Maleate | 211 | $5,040 | $24 |
| Xalatan | 16 | $4,757 | $297 |
| Pataday | 22 | $4,601 | $209 |
| Simbrinza | 15 | $3,413 | $228 |
| Olopatadine | 42 | $3,294 | $78 |
| Dorzolamide-Timolol | 134 | $3,072 | $23 |
| Cosopt | 12 | $2,427 | $202 |
| Dorzolamide | 86 | $1,803 | $21 |
| Ketorolac Tromethamine | 11 | $208 | $19 |
| Ciprofloxacin | 13 | $188 | $14 |
2016: 25 drugs
| Lumigan | 223 | $67,998 | $305 |
| Restasis | 87 | $38,198 | $439 |
| Combigan | 128 | $35,206 | $275 |
| Travatan Z | 95 | $24,083 | $254 |
| Azopt | 62 | $22,262 | $359 |
| Alphagan P | 73 | $17,885 | $245 |
| Brimonidine | 100 | $17,681 | $177 |
| Prednisolone Acetate | 194 | $12,292 | $63 |
| Zioptan | 58 | $11,179 | $193 |
| Durezol | 46 | $8,612 | $187 |
| Xalatan | 48 | $8,604 | $179 |
| Latanoprost | 575 | $7,823 | $14 |
| Acetazolamide | 37 | $7,712 | $208 |
| Cosopt Pf | 44 | $7,323 | $166 |
| Methazolamide | 35 | $6,976 | $199 |
| Pataday | 32 | $6,069 | $190 |
| Timoptic Ocudose | 15 | $5,311 | $354 |
| Simbrinza | 29 | $5,027 | $173 |
| Lotemax | 13 | $4,019 | $309 |
| Timolol Maleate | 192 | $2,956 | $15 |
| Timoptic-Xe | 14 | $2,524 | $180 |
| Cosopt | 12 | $2,426 | $202 |
| Dorzolamide-Timolol | 114 | $2,279 | $20 |
| Dorzolamide | 91 | $1,831 | $20 |
| Ciprofloxacin | 28 | $242 | $9 |
2015: 26 drugs
| Lumigan | 154 | $41,815 | $272 |
| Combigan | 109 | $25,255 | $232 |
| Azopt | 78 | $23,912 | $307 |
| Restasis | 60 | $23,410 | $390 |
| Travatan Z | 100 | $20,591 | $206 |
| Brimonidine | 122 | $19,723 | $162 |
| Alphagan P | 87 | $14,634 | $168 |
| Prednisolone Acetate | 160 | $9,257 | $58 |
| Timoptic Ocudose | 23 | $8,926 | $388 |
| Durezol | 32 | $6,692 | $209 |
| Latanoprost | 495 | $6,620 | $13 |
| Patanol | 15 | $4,980 | $332 |
| Pataday | 17 | $4,477 | $263 |
| Xalatan | 29 | $3,725 | $128 |
| Simbrinza | 26 | $3,581 | $138 |
| Acetazolamide | 15 | $2,887 | $192 |
| Nevanac | 13 | $2,866 | $220 |
| Timolol Maleate | 186 | $2,847 | $15 |
| Dorzolamide-Timolol | 106 | $2,711 | $26 |
| Methazolamide | 15 | $2,601 | $173 |
| Vigamox | 18 | $2,488 | $138 |
| Cosopt Pf | 19 | $2,230 | $117 |
| Zioptan | 15 | $2,165 | $144 |
| Dorzolamide | 73 | $1,786 | $24 |
| Ketorolac Tromethamine | 18 | $633 | $35 |
| Acyclovir | 19 | $294 | $15 |
2014: 25 drugs
| Lumigan | 188 | $39,452 | $210 |
| Travatan Z | 129 | $22,696 | $176 |
| Azopt | 115 | $20,305 | $177 |
| Brimonidine | 150 | $20,168 | $134 |
| Combigan | 106 | $17,127 | $162 |
| Restasis | 33 | $12,087 | $366 |
| Alphagan P | 66 | $11,767 | $178 |
| Prednisolone Acetate | 159 | $10,192 | $64 |
| Latanoprost | 395 | $5,724 | $14 |
| Durezol | 27 | $5,264 | $195 |
| Acetazolamide | 34 | $5,220 | $154 |
| Dorzolamide-Timolol | 171 | $5,001 | $29 |
| Patanol | 22 | $4,718 | $214 |
| Pataday | 20 | $4,396 | $220 |
| Nevanac | 13 | $3,030 | $233 |
| Timolol Maleate | 162 | $2,779 | $17 |
| Dorzolamide | 88 | $2,381 | $27 |
| Simbrinza | 19 | $2,293 | $121 |
| Xalatan | 16 | $1,887 | $118 |
| Vigamox | 12 | $1,340 | $112 |
| Methazolamide | 13 | $1,293 | $99 |
| Cosopt Pf | 14 | $1,237 | $88 |
| Azelastine | 20 | $1,012 | $51 |
| Acyclovir | 20 | $300 | $15 |
| Ketorolac Tromethamine | 13 | $282 | $22 |
2013: 19 drugs
| Lumigan | 131 | $26,811 | $205 |
| Travatan Z | 131 | $23,823 | $182 |
| Brimonidine | 162 | $21,212 | $131 |
| Azopt | 109 | $15,529 | $142 |
| Combigan | 93 | $13,687 | $147 |
| Alphagan P | 58 | $9,874 | $170 |
| Restasis | 24 | $8,356 | $348 |
| Latanoprost | 414 | $6,641 | $16 |
| Dorzolamide-Timolol | 158 | $5,329 | $34 |
| Prednisolone Acetate | 115 | $3,503 | $30 |
| Patanol | 19 | $3,483 | $183 |
| Timolol Maleate | 177 | $2,284 | $13 |
| Dorzolamide | 72 | $2,117 | $29 |
| Cosopt | 12 | $1,738 | $145 |
| Durezol | 13 | $1,442 | $111 |
| Zioptan | 13 | $1,366 | $105 |
| Methazolamide | 14 | $1,242 | $89 |
| Ketorolac Tromethamine | 13 | $252 | $19 |
| Acyclovir | 14 | $164 | $12 |
Money from drug and device companies
$20,483 in 2025
| 2025 | 7 | 49 | $18,150 | $20,483 |
| 2024 | 11 | 76 | $31,800 | $38,390 |
| 2023 | 9 | 49 | $7,820 | $11,988 |
| 2022 | 10 | 47 | $5,998 | $8,281 |
| 2021 | 9 | 41 | $8,424 | $10,619 |
| 2020 | 5 | 11 | $3,600 | $4,214 |
| 2019 | 6 | 20 | $8,873 | $11,524 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Voyager Dslt | $13,046 | 28 payments
|
| Alcon Research | Ngenuity | $4,000 | 4 payments
|
| Sight Sciences | Omni Surgical System | $1,469 | 6 payments
|
| Glaukos | Idosetr | $1,091 | 5 payments
|
| Abbvie | Durysta | $788 | 3 payments
|
| Bausch & Lomb Americas | Vyzulta | $65 | 2 payments
|
See all 49 published payments
| Bausch & Lomb Americas | Meals · 2025-12-22 | Vyzulta | $25 |
| Glaukos | Meals · 2025-12-17 | Istent Infinite | $23 |
| Glaukos | Meals · 2025-12-17 | Idosetr | $7 |
| Alcon Vision | Consulting · 2025-12-04 | Voyager Dslt | $4,000 |
| Bausch & Lomb Americas | Meals · 2025-11-18 | Vyzulta | $40 |
| Alcon Vision | Meals · 2025-11-14 | Hydrus Microstent | $144 |
| Alcon Vision | Meals · 2025-11-12 | Rocklatan | $37 |
| Alcon Vision | Meals · 2025-10-29 | Clareon | $69 |
| Glaukos | Consulting · 2025-10-29 | None | $800 |
| Alcon Vision | Meals · 2025-10-27 | Argos | $33 |
| Alcon Vision | Meals · 2025-10-23 | Rocklatan | $19 |
| Beaver-Visitec International | Meals · 2025-10-20 | None | $24 |
| Alcon Vision | Meals · 2025-10-16 | Hydrus Microstent | $86 |
| Alcon Vision | Consulting · 2025-10-09 | Voyager Dslt | $3,500 |
| Alcon Vision | Meals · 2025-09-17 | Hydrus Microstent | $52 |
| Alcon Vision | Meals · 2025-09-17 | Hydrus Microstent | $35 |
| Alcon Research | Consulting · 2025-09-04 | Ngenuity | $1,000 |
| Abbvie | Meals · 2025-08-26 | Durysta | $7 |
| Alcon Vision | Meals · 2025-08-26 | Hydrus Microstent | $23 |
| Alcon Vision | Meals · 2025-08-22 | Hydrus Microstent | $20 |
| Sight Sciences | Meals · 2025-07-17 | Omni Surgical System | $98 |
| Alcon Vision | Meals · 2025-06-05 | Clareon | $22 |
| Alcon Vision | Meals · 2025-06-04 | Clareon | $15 |
| Alcon Research | Consulting · 2025-05-22 | Ngenuity | $1,000 |
| Alcon Vision | Consulting · 2025-05-22 | Hydrus Microstent | $1,000 |
| Sight Sciences | Paid to speak or teach · 2025-05-15 | Omni Surgical System | $1,125 |
| Abbvie | Meals · 2025-04-27 | Xen Glaucoma Treatment System | $56 |
| Sight Sciences | Meals · 2025-04-26 | Omni Surgical System | $60 |
| Alcon Vision | Meals · 2025-04-25 | Hydrus Microstent | $77 |
| Glaukos | Meals · 2025-04-25 | Idosetr | $58 |
| Sight Sciences | Meals · 2025-04-17 | Omni Surgical System | $52 |
| Alcon Research | Consulting · 2025-04-10 | Ngenuity | $1,000 |
| Alcon Vision | Meals · 2025-04-07 | Clareon | $33 |
| Alcon Vision | Meals · 2025-03-15 | Hydrus Microstent | $82 |
| Alcon Vision | Meals · 2025-03-11 | Hydrus Microstent | $69 |
| Alcon Vision | Meals · 2025-02-28 | None | $119 |
| Alcon Vision | Meals · 2025-02-27 | Rocklatan | $149 |
| Alcon Vision | Meals · 2025-02-27 | Hydrus Microstent | $62 |
| Glaukos | Meals · 2025-02-26 | Idosetr | $203 |
| Alcon Vision | Meals · 2025-02-13 | Hydrus Microstent | $65 |
| Abbvie | Consulting · 2025-02-10 | Durysta | $725 |
| Alcon Vision | Meals · 2025-02-08 | Hydrus Microstent | $82 |
| Alcon Vision | Consulting · 2025-02-06 | Voyager Dslt | $3,000 |
| Sight Sciences | Meals · 2025-02-03 | Omni Surgical System | $10 |
| Alcon Vision | Meals · 2025-01-30 | Hydrus Microstent | $19 |
| Alcon Research | Consulting · 2025-01-23 | Ngenuity | $1,000 |
| Alcon Vision | Meals · 2025-01-21 | None | $85 |
| Sight Sciences | Meals · 2025-01-21 | Omni Surgical System | $124 |
| Alcon Vision | Meals · 2025-01-20 | Hydrus Microstent | $150 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $38,390
| Alcon Vision | Hydrus Microstent | $18,461 | 48 payments
|
| Alcon Research | Ngenuity | $11,728 | 7 payments
|
| Sight Sciences | Omni Surgical System | $3,364 | 5 payments
|
| Carl Zeiss Meditec | Cirrus Hd-Oct | $2,600 | 1 payment
|
| Glaukos | Idose | $1,524 | 5 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $204 | 2 payments
|
| Carl Zeiss Meditec USA | Cirrus Hd-Oct | $157 | 2 payments
|
| Bausch & Lomb Americas | Xipere | $139 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $81 | 1 payment
|
| Abbvie | Durysta | $77 | 3 payments
|
| Biogen | Byooviz | $54 | 1 payment
|
2023: $11,988
| Alcon Vision | Hydrus Microstent | $5,441 | 30 payments
|
| Sight Sciences | Omni Surgical System | $4,033 | 6 payments
|
| Carl Zeiss Meditec USA | Cirrus Hd-Oct | $1,163 | 4 payments
|
| Carl Zeiss Meditec | Artevo 800 | $650 | 1 payment
|
| Glaukos | None | $261 | 3 payments
|
| Harrow Eye | Iheezo | $125 | 1 payment
|
| AbbVie | Xen Glaucoma Treatment System | $121 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $105 | 2 payments
|
| Nova Eye | None | $90 | 1 payment
|
2022: $8,281
| Alcon Vision | Hydrus Microstent | $3,095 | 27 payments
|
| Alcon Research | None | $1,995 | 2 payments
|
| Sight Sciences | Omni(R) Surgical System (US) | $1,672 | 6 payments
|
| Ocular Therapeutix | Dextenza | $852 | 4 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $254 | 3 payments
|
| New World Medical | Kahook Dual Blade | $144 | 1 payment
|
| Carl Zeiss Meditec USA | Lumera 700 | $127 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $70 | 1 payment
|
| Biogen | None | $55 | 1 payment
|
| Iridex | None | $16 | 1 payment
|
2021: $10,619
| Sight Sciences | Omni(R) Surgical System (US) | $2,953 | 8 payments
|
| Ivantis | Hydrus Microstent | $2,949 | 7 payments
|
| Roche Products | None | $1,714 | 1 payment
|
| Omeros | Omidria | $1,564 | 2 payments
|
| Alcon Vision | Acrysof Iq Panoptix | $637 | 14 payments
|
| Aerie Pharmaceuticals | Rhopressa | $298 | 3 payments
|
| Ocular Therapeutix | Dextenza | $196 | 3 payments
|
| EyePoint Pharmaceuticals US | Dexycu | $182 | 2 payments
|
| Carl Zeiss Meditec USA | Artevo 800 | $124 | 1 payment
|
2020: $4,214
| Aerie Pharmaceuticals | Rhopressa | $3,792 | 3 payments
|
| New World Medical | Ahmed Glaucoma Valve | $194 | 1 payment
|
| Alcon Vision | Centurion | $125 | 4 payments
|
| Sight Sciences | Omni | $75 | 2 payments
|
| Allergan | None | $28 | 1 payment
|
2019: $11,524
| Allergan | Xen | $6,212 | 5 payments
|
| Iridex | None | $1,802 | 3 payments
|
| Boston Scientific | General Female Sui | $1,547 | 1 payment
|
| Aerie Pharmaceuticals | Rhopressa | $1,323 | 6 payments
|
| Sight Sciences | Omni | $603 | 4 payments
|
| Alcon Vision | Panoptix | $37 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Genentech, Inc. · 2024 | Their institution | $116,099 |
| Genentech, Inc. · Glaucoma Biorepository · 2022 | Their institution | $114,092 |
| Alcon Research LLC · Comparing Ngenuity Vs Conventional Microscope in A New Hydrus User · 2023 | Their institution | $67,088 |
| Genentech, Inc. · An Open Label Phase I Study To Evaluate the Correlation and Repeatability of Olleyes With Standard Automated Perimetry in Glaucoma · 2022 | Their institution | $62,139 |
| Genentech, Inc. · An Open-Label Phase I Study To Evaluate the Correlation and Repeatability of Olleyes With Standard Automated Perimetry in Glaucoma · 2021 | Their institution | $16,653 |
| F. Hoffmann-La Roche AG · Management of Ocular Adverse Events of Special Interest in Patients Implanted With the Port Delivery System With Ranibizumab Pds · 2022 | This clinician | $8,909 |
| Carl Zeiss Meditec, Inc. · Glaucoma Hfa / Oct Specificity Study · 2021 | Their institution | $5,120 |
| F. Hoffmann-La Roche AG · Management of Ocular Adverse Events of Special Interest in Patients Implanted With the Port Delivery System With Ranibizumab Pds · 2021 | This clinician | $3,910 |
| Genentech, Inc. · 2023 | Their institution | $3,569 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1417044280
- Licence
- CA A108857, FL ME99224, MO 2004011762California A108857: Current · expires 2028-12-31Florida ME99224: Active
- Trained
- University of Missouri, Columbia School of Medicine, 2002
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207WX0009X (207WX0009X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-10-05
- NPI last updated
- 2024-03-18
- NPI record certified
- 2024-03-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 900 Blake Wilbur Dr, Palo Alto, CA, 94304